The targeting mechanism of DHA ligand and its conjugate with Gemcitabine for the enhanced tumor therapy.
The targeting mechanism of DHA ligand and its conjugate with Gemcitabine for the enhanced tumor therapy.
复制标题
DHA配体及其与吉西他滨缀合物增强肿瘤治疗的靶向机制
DOI:
10.18632/oncotarget.1969
复制
发表时间:
2014-06-15
期刊:
影响因子:
--
通讯作者:
Gu Y
中科院分区:
文献类型:
--
作者:
Li S;Qin J;Tian C;Cao J;Fida G;Wang Z;Chen H;Qian Z;Chen WR;Gu Y
Docosahexaenoic acid (DHA), an omega-3 C22 natural fatty acid serving as a precursor for metabolic and biochemical pathways, was reported as a targeting ligand of anticancer drugs. However, its tumor targeting ability and mechanism has not been claimed. Here we hypothesized that the uptake of DHA by tumor cells is related to the phosphatidylethanolamine (PE) contents in cell membranes. Thus, in this manuscript, the tumor-targeting ability of DHA was initially demonstrated in vitro and in vivo on different tumor cell lines by labeling DHA with fluorescence dyes. Subsequently, the tumor targeting ability was then correlated with the contents of PE in cell membranes to study the uptake mechanism. Further, DHA was conjugated with anticancer drug gemcitabine (DHA-GEM) for targeted tumor therapy. Our results demonstrated that DHA exhibited high tumor targeting ability and PE is the main mediator, which confirmed our hypothesis. The DHA-GEM displayed enhanced therapeutic efficacy than that of GEM itself, indicating that DHA is a promising ligand for tumor targeted therapy.
登录
查看更多内容
影响因子:
37.3
作者:
Gelsomino G;Corsetto PA;Campia I;Montorfano G;Kopecka J;Castella B;Gazzano E;Ghigo D;Rizzo AM;Riganti C
通讯作者:
Riganti C
影响因子:
10.8
作者:
Bradley, MO;Swindell, CS;Donehower, RC
通讯作者:
Donehower, RC
影响因子:
2.8
作者:
Jing, Kaipeng;Wu, Tong;Lim, Kyu
通讯作者:
Lim, Kyu
影响因子:
50.5
作者:
Bedikian, A. Y.;DeConti, R. C.;Ernstoff, M.
通讯作者:
Ernstoff, M.
影响因子:
--
作者:
Guo, Jing;Du, Changli;Gu, Yueqing
通讯作者:
Gu, Yueqing